Perflubron
VARIOUS
Also known as: perfluoroctyl bromide, perfluorooctyl bromide
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Perflubron is an ofm drug catalogued in DrugCentral. It was first approved by the FDA in 1993.
- Approval status: ofm (first approved 1993 by the FDA).
- ATC code: V08CX01 (Other magnetic resonance imaging contrast media).
- Molecular formula: C8BrF17; molecular weight 498.96 g/mol.
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1993-08-13 | FDA | — | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
V08CX01 | VARIOUS › CONTRAST MEDIA › MAGNETIC RESONANCE IMAGING CONTRAST MEDIA › Other magnetic resonance imaging contrast media |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Perflubron is on its molecule page.
| Molecular formula | C8BrF17 |
|---|---|
| Molecular weight | 498.96 g/mol |
| CAS number | 423-55-2 |
| InChIKey | WTWWXOGTJWMJHI-UHFFFAOYSA-N |
| PubChem CID | 9873 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
When was Perflubron first approved?
Perflubron was first approved by the FDA in 1993.
What is the chemical formula of Perflubron?
Perflubron has the molecular formula C8BrF17 and a molecular weight of 498.96 g/mol.
Browse: all drugs starting with P · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 2102 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1200866 — compound record and bioactivity
- PubChem CID 9873 — chemical identifiers
- DrugBank DB05791 — drug record
- FDA UNII Q1D0Q7R4D9 — substance identity
- DailyMed: FDA labels for Perflubron — current prescribing information (label search)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.